Format
Sort by
Items per page

Send to

Choose Destination

Links from OMIM

Items: 1 to 20 of 56

1.

[Porphyrias].

Stölzel U, Stauch T, Doss MO.

Internist (Berl). 2010 Dec;51(12):1525-33; quiz 1534. doi: 10.1007/s00108-010-2751-x. Review. German.

PMID:
21104216
2.

Induction of hepatic aminolevulinate acid synthetase activity by isoflurane in a genetic model for erythropoietic protoporphyria.

Buzaleh AM, Morán-Jiménez MJ, Garcia-Bravo M, Sampedro A, Batlle AM, Enriquez de Salamanca R, Fontanellas A.

Cell Mol Biol (Noisy-le-grand). 2009 Feb 16;55(1):38-44.

PMID:
19268000
3.

Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells.

Robert-Richard E, Moreau-Gaudry F, Lalanne M, Lamrissi-Garcia I, Cario-André M, Guyonnet-Dupérat V, Taine L, Ged C, de Verneuil H.

Am J Hum Genet. 2008 Jan;82(1):113-24. doi: 10.1016/j.ajhg.2007.09.007.

4.

Porphyria cutanea tarda as the most common porphyria.

Bulat V, Lugović L, Situm M, Buljan M, Bradić L.

Acta Dermatovenerol Croat. 2007;15(4):254-63. Review.

PMID:
18093456
5.

Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions.

Bishop DF, Johansson A, Phelps R, Shady AA, Ramirez MC, Yasuda M, Caro A, Desnick RJ.

Am J Hum Genet. 2006 Apr;78(4):645-58. Epub 2006 Feb 9.

6.

Hepatic porphyrias.

Scarlett YV, Brenner DA, Bloomer JR.

Clin Liver Dis. 1998 Feb;2(1):77-102, vi. Review.

PMID:
15560047
7.

Some studies of the comparative biology of human and bovine porphyria erythropoietica.

WATSON CJ, PERMAN V, SPURRELL FA, HOYT HH, SCHWARTZ S.

Trans Assoc Am Physicians. 1958;71:196-209. No abstract available.

PMID:
13603517
8.

Diagnosis and treatment of the hepatic porphyrias.

Lecha M, Herrero C, Ozalla D.

Dermatol Ther. 2003;16(1):65-72. Review.

PMID:
12919129
9.

[Nephrologists and porphyrias].

Canavese C, Gabrielli D, Guida C, Cappellini MD.

G Ital Nefrol. 2002 Jul-Aug;19(4):393-412. Review. Italian.

PMID:
12369042
10.

Congenital erythropoietic porphyria: advances in pathogenesis and treatment.

Desnick RJ, Astrin KH.

Br J Haematol. 2002 Jun;117(4):779-95. Review. No abstract available.

PMID:
12060112
11.

Porphyrins, porphyrin metabolism and porphyrias. I. Update.

Thunell S.

Scand J Clin Lab Invest. 2000 Nov;60(7):509-40. Review.

PMID:
11202048
12.

Erythropoietic and hepatic porphyrias.

Gross U, Hoffmann GF, Doss MO.

J Inherit Metab Dis. 2000 Nov;23(7):641-61. Review.

PMID:
11117426
13.

Alcohol and porphyrin metabolism.

Doss MO, Kühnel A, Gross U.

Alcohol Alcohol. 2000 Mar-Apr;35(2):109-25. Review.

PMID:
10787385
14.

Hematologic aspects of the porphyrias.

Sassa S.

Int J Hematol. 2000 Jan;71(1):1-17. Review.

PMID:
10729988
15.

Spontaneous porphyria of the Long-evans cinnamon rat: an animal model of Wilson's disease.

Nakayama K, Takasawa A, Terai I, Okui T, Ohyama T, Tamura M.

Arch Biochem Biophys. 2000 Mar 15;375(2):240-50.

PMID:
10700380
16.

The cutaneous porphyrias.

Lim HW, Cohen JL.

Semin Cutan Med Surg. 1999 Dec;18(4):285-92. Review.

PMID:
10604794
17.

Effects of selected antihypertensives and analgesics on hepatic porphyrin accumulation: implications for clinical porphyria.

Lambrecht RW, Gildemeister OS, Williams A, Pepe JA, Tortorelli KD, Bonkovsky HL.

Biochem Pharmacol. 1999 Sep 1;58(5):887-96.

PMID:
10449201
18.

Congenital erythropoietic porphyria successfully treated by allogeneic bone marrow transplantation.

Tezcan I, Xu W, Gurgey A, Tuncer M, Cetin M, Oner C, Yetgin S, Ersoy F, Aizencang G, Astrin KH, Desnick RJ.

Blood. 1998 Dec 1;92(11):4053-8.

19.

Porphyrias.

Scarlett YV, Brenner DA.

J Clin Gastroenterol. 1998 Oct;27(3):192-8. Review.

PMID:
9802444
20.

Effects of new anticonvulsant medications on porphyrin synthesis in cultured liver cells: potential implications for patients with acute porphyria.

Hahn M, Gildemeister OS, Krauss GL, Pepe JA, Lambrecht RW, Donohue S, Bonkovsky HL.

Neurology. 1997 Jul;49(1):97-106.

PMID:
9222176

Supplemental Content

Support Center